Wyss Institute at Harvard University
Dana-Farber Cancer Immunology Seminar Series
Time: 1:00 pm - 2:00 pm
Zoom link: https://dfci.zoom.us/j/91621307314?pwd=KzQzRWI3azFKdnNVa2VYOXBOYy9nUT09
Passcode: 757346
| Date and Time | Speaker Sort ascending | Institution | Seminar Title |
|---|---|---|---|
| Yvonne Chen, Ph.D. | University of California, Los Angeles | Engineering Next-Generation CAR-T Cell Therapy for Cancer (Co-sponsored by the Harvard i3 Center and DFCI ) |
|
| William Sellers, MD | Broad Institute | Functional Genomic Approaches to the Discovery of Paralog Dependencies in Cancer | |
| Viviana Cremasco, PhD | Novartis Institutes for Biomedical Research | Stroma-imposed immune regulation | |
| Stefanie Vogel, PhD | University of Maryland | Targeting Host Responses to Mitigate Influenza-induced Severe Disease | |
| Stefani Spranger, PhD | MIT | The impact of dendritic cells on anti-tumor T cell responses | |
| Sloan Devlin, PhD | Harvard Medical School | Gut Bacterial Modification of Bile Acids Alters Host Physiology | |
| Seth Rakoff-Nahoum, MD, PhD | Boston Children's Hospital | ||
| Robert Seder, MD | National Institutes of Health | Peptide-TLR-7/8 Agonist Vaccine is a Tunable Platform for Altering the Magnitude, Quality and Breadth of Neoantigen CD8 T Cell Responses (Co-sponsored by the Harvard i3 Center and DFCI ) |
|
| Pulin Li, PhD | MIT | Spatial Control of Cell-Cell Communication: From Genes to Circuits | |
| Professor Samir Mitragotri | Harvard John A. Paulson School of Engineering & Applied Sciences | (Co-sponsored by the Harvard i3 Center and DFCI ) | |
| Nina Bhardwaj, MD, PhD | Mount Sinai | Overcoming Resistance to Immunotherapy: Targeting Innate Immune Cells | |
| Michelle Kelliher, PhD | UMass Chan Medical School | Understanding Glucocorticoid Resistance and Relapse in T-ALL Mouse Models | |
| Michele De Palma | EPFL (Swiss Federal Institute of Technology in Lausanne) | ||
| Michael Dustin | Oxford University | Engaging the Immunological Synapse in Cancer Therapy | |
| Michael Dougan, MD, PhD | Massachusetts General Hospital | Using Immunotherapy to Understand Immune Regulation in the Gut | |
| Michael Birnbaum, PhD | MIT | Decoding Immune Recognition | |
| Matthias Stephan, MD, PhD | Fred Hutchinson Cancer Research Center | Creating Living Drugs with Synthetic Compounds (Co-sponsored by the Harvard i3 Center and DFCI ) |
|
| Matthew Vander Heiden, MD, PhD | MIT | Environmental Influence on Tumor Metabolism | |
| Markus Frank, MD | Boston Children's Hospital | ABCB5-Mediated Cancer Resistance to Targeted and Immunotherapeutic Treatment Modalities | |
| Maria Rescigno, PhD | Humanitas University | The Microbiota in Cancer Progression and Treatment | |
| Marcia Haigis, PhD | Harvard Medical School | ||
| Manuel Valiente, PhD | Centro Nacional de Investigaciones Oncológicas | Strategies to Challenge Brain Metastatis Lethality in Mice and Human | |
| Luke Gilbert, PhD | UCSF | Modeling Human Genetic Interactions and Disease at Single Cell Resolution Using CRISPR Functional Genomics | |
| Kole Roybal | University of California, San Francisco | ||
| Kevin Haigis, PhD | Dana-Farber Cancer Institute | Pathogenic Epithelial-Immune Interactions in the Gastrointestinal Tract | |
| Ken Murphy | Washington University in St. Louis | Development and Dynamic Regulation of cDC1 in Homeostasis and Cancer | |
| Katelyn Byrne, PhD | Parker Institute for Cancer Immunotherapy | Strategies for Overcoming the Suppressive Pancreatic Tumor Microenvironment | |
| Kate Jeffrey, PhD | Massachusetts General Hospital | Epigenome and Virome Immunomodulation in the Gut | |
| Justin Eyquem | University of California, San Francisco | ||
| Julie Magarian Blander, PhD | Cornell University | Regulation of Cross-Presentation by Dendritic Cells | |
| Jose Ordovas-Montanes, PhD | Boston Children's Hospital | Single-Cell Biology of Barrier Tissues and COVID-19 | |
| Joan Brugge, PhD | Harvard Medical School | ||
| Jessica Thaxton, PhD | University of North Carolina | Stress-Mediated Attenuation of Translation Undermines T Cell Tumor Control | |
| Jeffrey Hubbell, PhD | University of Chicago | Cytokine Engineering to Modulate the Tumor Microenvironment (Co-sponsored by the Harvard i3 Center and DFCI ) |
|
| James Moon, PhD | University of Michigan | Engineering Strategies to Modulate the Gut Microbiome and Immune System (Co-sponsored by the Harvard i3 Center and DFCI ) |
|
| Ioannis Zervantonakis, PhD | University of Pittsburgh | Modeling Cell-Cell Interactions in the Tumor Microenvironment Using Microfluidics (Co-sponsored by the Harvard i3 Center and DFCI ) |
|
| Gwendalyn Randolph, PhD | Washington University | ||
| Gerhard Wagner, PhD | Harvard Medical School | Cytocapsular Tubes: New Dimension in Cancer Biology and Treatment | |
| Francisco Quintana, PhD | Brigham and Women's Hospital | Immunosuppressive Astrocyte Subsets | |
| Florian Schmidt, PhD | Univeristy of Bonn | Interrogating Infection and Immunity with Camelid Nanobodies | |
| Federica Sallusto, PhD | ETH Zurich | One for All: Cross-Reactive T Cells and Antibodies to Coronaviruses | |
| Edward Chouchani, PhD | Dana-Farber Cancer Institute | Mechanisms of Metabolite Regulation Over Health & Disease | |
| Dr. Suzie Pun | University of Washington | Biomaterials for Immunoengineering (Co-sponsored by the Harvard i3 Center and DFCI ) |
|
| David Knipe, PhD | Harvard Medical School | Linking Adaptive Immunity to Epigenetic Silencing of Herpesviruses | |
| Darrell Irvine, PhD | MIT | Engineering Timing and Location of Immunotherapy to Enhance Anti-Tumor Immunity (Co-sponsored by the Harvard i3 Center and DFCI ) |
|
| Daniel Schramek, PhD | Lunenfeld/Tanenbaum Research Institute | In Vivo Veritas – using CRISPR to Delineate Cancer Genes and Immune Regulators | |
| Daniel McVicar | NIH | ||
| Dan Barouch, MD, PhD | Beth Israel Deaconess Medical Center | COVID-19: Developing a Vaccine During a Pandemic | |
| Cigall Kadoch, PhD | Dana-Farber Cancer Institute | Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Cancer | |
| Christina Towers | Salk Institute | Mechanisms to Circumvent Autophagy Inhibition in Cancer | |
| Carrie Lucas, Ph.D. | Yale University | Immunobiology Illuminated by Pediatric Inflammatory Disorders | |
| Caroline Sokol, MD, PhD | Massachusetts General Hospital | Neuro-immune Recognition of Allergens | |
| Caetano Reis e Sousa, DPhil | The Francis Crick Institte | ||
| Bronwyn MacInnis and Katie Siddle, PhDs | Broad Institute | Genomic Epidemiology of SARS-CoV-2 in Massachusetts | |
| Ankur Singh, PhD | Georgia Institute of Technology | Organoids to study cooperative signaling, epigenetics, and therapeutic resistance in human cancers (Co-sponsored by the Harvard i3 Center and DFCI ) |
|
| Andy Minn, MD, PhD | University of Pennsylvania | Decoding and Recoding the Opposing Roles of Interferon and Pattern Recognition Receptor Signaling in Cancer Immunotherapy | |
| Andrew Kruse, PhD | Harvard Medical School | Antibody Fragments as Tools to Interrogate G protein-coupled Receptor Signaling | |
| Amy Moran | Oregon Health & Science University | ||
| Amanda Lund, PhD | NYU Langone Health | Investigating the Immunological Implications of Lymphatic Transport in Skin and Melanoma | |
| Alexander Marson | University of California, San Francisco | Programming T Cell Therapies with CRISPR | |
| Adam Bass, MD | Dana-Farber Cancer Institute | Unexpected immune interactions from studies of lineage oncogenes in squamous cell carcinoma |
Copyright © The President and Fellows of Harvard College